☆ 4.7 Letter

Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study

RHEUMATOLOGY (2020)

Get Full Text
Add to Collection

Journal

RHEUMATOLOGY
Volume 59, Issue 9, Pages E46-E47

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keaa253

Keywords

-

Categories

Rheumatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Rheumatology

Listeriosis presenting with fever, arthralgia, elevated liver enzymes, and hyperferritinaemia in pregnancy: a critical mimicker of adult-onset Still's disease

T. Kitada, K. Kadoba, R. Watanabe, T. Koyama, Y. Nakayama, M. Taki, S. Yukawa, K. Odani, A. Morinobu

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2022)

Add to Collection
Article Rheumatology

Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort study

Y. Nakayama, M. Hashimoto, R. Watanabe, K. Murakami, K. Murata, M. Tanaka, H. Ito, W. Yamamoto, K. Ebina, K. Hata, Y. Hiramatsu, M. Katayama, Y. Son, H. Amuro, K. Akashi, A. Onishi, R. Hara, K. Yamamoto, K. Ohmura, S. Matsuda, A. Morinobu

Summary: IL-6Ri may be a favorable therapeutic option over TNFi and CTLA4-Ig in RA patients with high CRP levels, as indicated by significantly higher 3-year drug retention rates. However, no significant difference was found in terms of CDAI 12 months after bDMARD initiation among different CRP tertile groups.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2022)

Add to Collection
Article Rheumatology

Perceptions and behaviours related to COVID-19 in patients with rheumatoid arthritis: a cross-sectional study

Takahiro Itaya, Mie Torii, Motomu Hashimoto, Kazuaki Jindai, Wataru Yamamoto, Kyosuke Tanigawa, Yuki Urai, Ayae Kinoshita, Kazuko Nin, Ryu Watanabe, Koichi Murata, Kosaku Murakami, Masao Tanaka, Hiromu Ito, Shuichi Matsuda, Akio Morinobu

Summary: Patients with rheumatoid arthritis showed concerns about COVID-19 during the pandemic, but most believed the risk of infection was low. Those with low health literacy had limited knowledge about COVID-19 and were less likely to change behaviors. Healthcare providers should pay attention to vulnerable individuals and effectively communicate COVID-19 related information.

CLINICAL RHEUMATOLOGY (2022)

Add to Collection
Article Rheumatology

Clinical profile and outcome of large-vessel giant cell arteritis in Japanese patients: A single-centre retrospective cohort study

Eriho Yamaguchi, Keiichiro Kadoba, Ryu Watanabe, Takeshi Iwasaki, Koji Kitagori, Shuji Akizuki, Kosaku Murakami, Ran Nakashima, Motomu Hashimoto, Masao Tanaka, Akio Morinobu, Hajime Yoshifuji

Summary: This study compared the clinical characteristics and outcomes between patients with giant cell arteritis (GCA) with or without large vessel involvement (LVI). The results showed that GCA without LVI had more active disease, severer vascular damage, and worse survival.

MODERN RHEUMATOLOGY (2023)

Add to Collection
Article Rheumatology

Autoantibody profiles associated with morbidity and mortality in scleroderma renal crisis

Hideaki Tsuji, Nobuo Kuramoto, Tsuneo Sasai, Mirei Shirakashi, Hideo Onizawa, Koji Kitagori, Shuji Akizuki, Ran Nakashima, Ryu Watanabe, Akira Onishi, Kosaku Murakami, Hajime Yoshifuji, Masao Tanaka, Motomu Hashimoto, Koichiro Ohmura, Akio Morinobu

Summary: Specific SSc-related autoantibodies are associated with the morbidity and mortality of SRC. Anti-topoisomerase I, anti-RNAPIII, and anti-U1-RNP are associated with the development of SRC, while anti-topoisomerase I is associated with 1-year mortality of SRC.

RHEUMATOLOGY (2022)

Add to Collection
Letter Rheumatology

Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis

Ryu Watanabe, Motomu Hashimoto

RHEUMATOLOGY (2022)

Add to Collection
Article Rheumatology

Effect of Impaired T Cell Receptor Signaling on the Gut Microbiota in a Mouse Model of Systemic Autoimmunity

Mirei Shirakashi, Mikako Maruya, Keiji Hirota, Tatsuaki Tsuruyama, Takashi Matsuo, Ryu Watanabe, Koichi Murata, Masao Tanaka, Hiromu Ito, Hajime Yoshifuji, Koichiro Ohmura, Dirk Elewaut, Shimon Sakaguchi, Sidonia Fagarasan, Tsuneyo Mimori, Motomu Hashimoto

Summary: This study reveals that defective TCR signaling alters the gut microbiota, promotes Th17 cell differentiation, and triggers systemic autoimmunity, which is a significant finding for understanding the pathogenesis of SLE.

ARTHRITIS & RHEUMATOLOGY (2022)

Add to Collection
Article Rheumatology

Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1

Kohei Doi, Koichi Murata, Shuji Ito, Akari Suzuki, Chikashi Terao, Shinichiro Ishie, Akio Umemoto, Yoshiki Murotani, Kohei Nishitani, Hiroyuki Yoshitomi, Takayuki Fujii, Ryu Watanabe, Motomu Hashimoto, Kosaku Murakami, Masao Tanaka, Hiromu Ito, Kyung-Hyun Park-Min, Lionel B. Ivashkiv, Akio Morinobu, Shuichi Matsuda

Summary: This study reveals the metabolic role of LSD1 in regulating inflammatory bone resorption in patients with rheumatoid arthritis, providing potential new therapeutic strategies for the management of inflammatory arthritis.

ARTHRITIS & RHEUMATOLOGY (2022)

Add to Collection
Review Rheumatology

Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis

Ryu Watanabe, Megumi Oshima, Norihiro Nishioka, Ken-Ei Sada, Kenji Nagasaka, Mitsuhiro Akiyama, Taiki Ando, Tomoaki Higuchi, Yoshino Inoue, Takashi Kida, Tomoyuki Mutoh, Akihiko Nakabayashi, Akira Onishi, Ryota Sakai, Daisuke Waki, Yosuke Yamada, Nobuyuki Yajima, Naoto Tamura, Shinya Kaname, Masayoshi Harigai

Summary: This study provides evidence for the revision of clinical practice guidelines for the management of ANCA-associated vasculitis, including treatment strategies for remission induction and remission maintenance.

MODERN RHEUMATOLOGY (2023)

Add to Collection
Article Rheumatology

High plasma homocysteine level is associated with increased prevalence of the non-remission state in rheumatoid arthritis: Findings from the KURAMA cohort

Masao Katsushima, Hiroto Minamino, Mirei Shirakashi, Akira Onishi, Yoshihito Fujita, Wataru Yamamoto, Hideo Onizawa, Hideaki Tsuji, Ryu Watanabe, Kosaku Murakami, Takayuki Fujii, Koichi Murata, Masao Tanaka, Nobuya Inagaki, Akio Morinobu, Motomu Hashimoto

Summary: This study aimed to determine the clinical impact of plasma homocysteine levels on disease activity and clinical remission in patients with rheumatoid arthritis (RA). The results showed that increased plasma homocysteine levels were significantly associated with current disease activity and the non-remission state.

MODERN RHEUMATOLOGY (2023)

Add to Collection
Review Rheumatology

Management of sarcopenia in patients with rheumatoid arthritis

Mie Torii, Takahiro Itaya, Hiroto Minamino, Masao Katsushima, Yoshihito Fujita, Hiroki Tanaka, Yohei Oshima, Ryu Watanabe, Hiromu Ito, Hidenori Arai, Motomu Hashimoto

Summary: This review summarizes the evidence for the management of sarcopenia in patients with rheumatoid arthritis (RA) in terms of drugs, exercise, and nutrition. The prevalence of sarcopenia in patients with RA is higher than that in the general population, making the treatment and management of sarcopenia clinically important for long-term prognosis. However, there remains a lack of concrete evidence on sarcopenia treatment and management in patients with RA, and more longitudinal and intervention studies are needed in the future.

MODERN RHEUMATOLOGY (2023)

Add to Collection
Article Immunology

Baseline erythrocyte sedimentation rate level predicts long-term inhibition of radiographic progression by tocilizumab: the KURAMA cohort

Ryu Watanabe, Kosaku Murakami, Toshimitsu Fujisaki, Hiromu Ito, Koichi Murata, Wataru Yamamoto, Takayuki Fujii, Hideo Onizawa, Akira Onishi, Masao Tanaka, Akio Morinobu, Motomu Hashimoto

Summary: The long-term effects of tocilizumab on joint destruction in rheumatoid arthritis patients were evaluated in this study. The results showed that patients who achieved structural remission were relatively younger, had a higher proportion of anti-citrullinated protein antibody positivity, and lower levels of C-reactive protein and erythrocyte sedimentation rate. Multivariate logistic regression analysis demonstrated that the baseline erythrocyte sedimentation rate level was significantly associated with structural remission.

IMMUNOLOGICAL MEDICINE (2023)

Add to Collection
Review Biochemistry & Molecular Biology

Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors-A 2023 Update

Quang Minh Dang, Ryu Watanabe, Mayu Shiomi, Kazuo Fukumoto, Tomomi W. Nobashi, Tadashi Okano, Shinsuke Yamada, Motomu Hashimoto

Summary: With the increase in elderly patients, malignancies are becoming more common in rheumatoid arthritis (RA) patients and often pose challenges to RA treatment. Immune checkpoint inhibitors (ICIs) have emerged as a promising treatment option for various malignancies by blocking immunological brakes on T lymphocytes. However, ICIs are also associated with numerous immune-related adverse events (irAEs) including hypophysitis, myocarditis, pneumonitis, and colitis. Moreover, ICIs can exacerbate existing autoimmune diseases and cause rheumatic irAEs such as arthritis, myositis, and vasculitis. This review provides a comprehensive summary of the mechanisms, management, and potential therapeutic strategies for rheumatic irAEs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection
Review Medicine, General & Internal

Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations

Ryu Watanabe, Motomu Hashimoto

Summary: This review summarizes the latest knowledge on the pathophysiology of eosinophilic granulomatosis with polyangiitis (EGPA) and focuses on the roles of eosinophils and antineutrophil cytoplasmic antibody (ANCA). Furthermore, it introduces the current treatment recommendations and accumulated evidence for mepolizumab on EGPA. Based on current unmet clinical needs, potential future therapeutic strategies for EGPA are discussed.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection
Letter Rheumatology

Correspondence on 'The use of tocilizumab and tofacitinib in patients with resolved hepatitis B infection: a case series'

Ryu Watanabe, Motomu Hashimoto, Akio Morinobu

ANNALS OF THE RHEUMATIC DISEASES (2023)

Add to Collection
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.